Surfix Diagnostics develops diagnostic tests for the early detection and monitoring of cancer utilizing its photonic diagnostics platform that combines six state-of-the-art technologies. To make it even more exciting: this photonic diagnostics platform is so versatile that it can be used for immunoassays AND for molecular diagnostics. Any protein or nucleic acid-based biomarker in a liquid biopsy can be detected, provided a suitable bioreceptor to capture this biomarker is available.

The core of Surfix’s photonic diagnostics platform is a photonic biosensor consisting of a photonic biochip and a microfluidic cartridge both optimized with Surfix's proprietary nanocoatings. The biosensor is used in combination with a dedicated desktop reader.

Life Sciences

Biotechnology

Medical Devices

Surfix Diagnostics

Jos Lunenberg

Nadieh Kuijpers

Ricardo Krabbenborg

Henk Van Middendorp

Geert Besselink

Colin Bartel

Arthur Blom

Research and Development

Leadership Team

��

Surfix Diagnostics

Org chart

Teams

Research and Development

Leadership Team

Similar companies

��������

Surfix Diagnostics

Org chart

Teams

Research and Development

Leadership Team

Similar companies

��